Centene Corp
F:QEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Centene Corp
F:QEN
|
US |
|
A
|
Alnylam Pharmaceuticals Inc
XMUN:DUL
|
US |
|
E
|
Electronic Arts Inc
XMUN:ERT
|
US |
Shareholder Yield
Current shareholder yield for 
QEN is
.
Peers Comparison
Shareholder Yield
Debt Paydown
Not Applicable
Due to the unique financial structures and regulatory environments of banks and insurance companies, the Debt Paydown metric is not applicable for Centene Corp.
These institutions manage liabilities differently, focusing more on regulatory compliance and operational liabilities than traditional debt management, making standard debt paydown calculations irrelevant.
Price Appreciation
QEN Price
Centene Corp
| Average Annual Return | -0.14% |
| Standard Deviation of Annual Returns | 14.57% |
| Max Drawdown | -78% |
| Market Capitalization | 32.3B EUR |
| Shares Outstanding | 536 383 000 |
| Percentage of Shares Shorted |
N/A
|
QEN Return Decomposition
Main factors of price return
Stock Splits
QEN's latest stock split occurred on Feb 7, 2019
The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.
Before the split, QEN traded at 109.9 per share. Afterward, the share price was about 56.54.
The adjusted shares began trading on Feb 7, 2019. This was stock split number 2 in QEN's history, following the previous one in Feb 20, 2015.
